Nika Pharmaceuticals (NIKA) Cash & Equivalents (2020 - 2026)
Nika Pharmaceuticals (NIKA) reported Cash & Equivalents of $864.00 for Q4 2023, unchanged from $864.00 a year earlier and down 92.1% from the prior quarter.
Powered by 
Analysis
Nika Pharmaceuticals (NIKA) Cash & Equivalents (2020 - 2026) Analysis & Trends
Dating back to Q1 2021, Nika Pharmaceuticals' Cash & Equivalents record includes 11 quarters.
- By year, Cash & Equivalents came in at $864.00 in FY2022 (+116.5%) and $399.00 in FY2021.
- Five-year quarterly Cash & Equivalents spans a low of $83.00 in Q1 2022 and a high of $11,053 in Q2 2023.
- Year over year, Cash & Equivalents gained in four of the last six quarters, with growth averaging 60.2%.
- Per Business Quant data, the three quarters before Q4 2023 came in at $10,910 (Q3 2023), $11,053 (Q2 2023) and $4,459 (Q1 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Nika Pharmaceuticals | 369.14 Mn | 369.13 Mn | - | 352.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 352.00 |
| Jun 30, 2026 | 2,932.00 |
| Mar 31, 2026 | 1,530.00 |
| Dec 31, 2025 | 1,889.00 |
| Sep 30, 2025 | 6,287.00 |
| Jun 30, 2025 | 15,616.00 |
| Mar 31, 2025 | 19,137.00 |
| Dec 31, 2024 | 2,083.00 |
| Sep 30, 2024 | 1,386.00 |
| Jun 30, 2024 | 7,486.00 |
| Mar 31, 2024 | 24,466.00 |
| Dec 31, 2023 | 864.00 |
| Sep 30, 2023 | 10,910.00 |
| Jun 30, 2023 | 11,053.00 |
| Mar 31, 2023 | 4,459.00 |
| Dec 31, 2022 | 864.00 |
| Sep 30, 2022 | 3,914.00 |
| Jun 30, 2022 | 8,545.00 |
| Mar 31, 2022 | 83.00 |
| Dec 31, 2021 | 399.00 |
API Access
Nika Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NIKA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "NIKA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NIKA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();